Market Research Finds 99% Of US Clinical Cardiologists Surveyed Report a High Unmet Need for New Innovative Drug Treatments for Early Cardiogenic Shock Patients (ECS) as Windtree Therapeutics Prepares for Clinical Results from its Istaroxime ECS Study
12 oct. 2021 07h30 HE
|
Windtree Therapeutics
WARRINGTON, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
16 sept. 2021 07h30 HE
|
Windtree Therapeutics
WARRINGTON, Pa., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions...
Windtree Therapeutics Reports Second Quarter 2021 Financial Results and Provides Key Business Updates
05 août 2021 16h01 HE
|
Windtree Therapeutics
WARRINGTON, Pa., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree Appoints Randall White, Ph.D., as Vice President, Clinical Program Management
02 août 2021 08h00 HE
|
Windtree Therapeutics
WARRINGTON, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree to Present at Access to Giving Virtual Investor Conference
08 juil. 2021 07h30 HE
|
Windtree Therapeutics
WARRINGTON, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree to Present at the Ladenburg Thalmann 2021 Healthcare Conference (Virtual)
07 juil. 2021 07h30 HE
|
Windtree Therapeutics
WARRINGTON, Pa., July 07, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for...
Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
13 août 2020 19h36 HE
|
Windtree Therapeutics
WARRINGTON, Pa., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NASDAQ: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical...
Windtree Therapeutics to Present at the Fall Investor Summit
10 sept. 2019 08h00 HE
|
Windtree Therapeutics
WARRINGTON, Pa., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical...